Field Evaluation of the Efficacy of Mycobacterium Bovis Bacillus Calmette-Guerin Against Bovine Tuberculosis in Neonatal Calves in Ethiopia

Overview

Journal Clin Vaccine Immunol

Publisher American Society for Microbiology

Specialties Allergy & Immunology
Pathology

Date 2010 Aug 20

PMID 20719984

Citations 33

Authors

Gobena Ameni

Martin Vordermeier

Abraham Aseffa

Douglas B Young

R Glyn Hewinson

Affiliations

Soon will be listed here.

Abstract

In developing countries, the conventional test and slaughter strategy for the control of bovine tuberculosis is prohibitively expensive, and alternative control methods such as vaccination are urgently required. In this study, the efficacy of Mycobacterium bovis bacillus Calmette-Guérin (BCG) for protection against bovine tuberculosis (bTB) was evaluated in Holstein calves under field conditions in Ethiopia. Thirteen neonatally vaccinated and 14 control calves were exposed for 10 to 23 months to skin test reactor cows. Gamma interferon (IFN-γ) testing, comparative intradermal tuberculin testing, postmortem examination, and bacteriological culture were used for the evaluation of BCG efficacy. The overall mean pathology score was significantly (P < 0.05) higher in control calves than in vaccinated calves. Culture positivity for Mycobacterium bovis was higher in the control calves than in the vaccinated calves, and significantly more BCG-vaccinated animals would have passed a standard meat inspection (P = 0.021). Overall, the protective efficacy of BCG was between 56% and 68%, depending on the parameters selected. Moreover, by measuring gamma interferon responses to the antigens ESAT-6 and CFP-10, which are present in M. bovis but absent from BCG, throughout the experiment, we were able to distinguish between vaccinated animals that were protected against bTB and those animals that were not protected. In conclusion, the present trial demonstrated an encouraging protective effect of BCG against bTB in a natural transmission setting in Ethiopia.

Citing Articles

Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings.

Fromsa A, Conlan A, Srinivasan S, Gumi B, Bedada W, Zeleke M Sci Rep. 2025; 15(1):4564.

PMID: 39915566 PMC: 11802902. DOI: 10.1038/s41598-025-85389-1.

Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis.

Niroula N, Ghodasara P, Marreros N, Fuller B, Sanderson H, Zriba S Sci Rep. 2025; 15(1):3764.

PMID: 39885300 PMC: 11782570. DOI: 10.1038/s41598-025-88176-0.

Field Trial with Vaccine Candidates Against Bovine Tuberculosis Among Likely Infected Cattle in a Natural Transmission Setting.

Ferrara Muniz X, Garcia E, Blanco F, Garbaccio S, Garro C, Zumarraga M Vaccines (Basel). 2024; 12(10).

PMID: 39460339 PMC: 11512252. DOI: 10.3390/vaccines12101173.

The safety of overdose and repeat administrations of BCG Danish strain 1331 vaccine in calves and pregnant heifers.

Williams G, Allen D, Brewer J, Salguero F, Houghton S, Vordermeier H Heliyon. 2024; 10(14):e34683.

PMID: 39149000 PMC: 11325048. DOI: 10.1016/j.heliyon.2024.e34683.

The Establishment of a Novel γ-Interferon In Vitro Release Assay for the Differentiation of -Infected and BCG-Vaccinated Cattle.

Zhao Y, Fei W, Yang L, Xiang Z, Chen X, Chen Y Vet Sci. 2024; 11(5).

PMID: 38787170 PMC: 11125845. DOI: 10.3390/vetsci11050198.

References

Sidders B, Pirson C, Hogarth P, Hewinson R, Stoker N, Vordermeier H . Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex. Infect Immun. 2008; 76(9):3932-9. PMC: 2519431. DOI: 10.1128/IAI.00150-08. View

Cheneau Y, Blancou J . [Comparative values of live or killed BCG and trypsinized Koch's bacillus in the immunization of zebu against tuberculosis]. Rev Elev Med Vet Pays Trop. 1975; 28(1):1-7. View

Waters W, Palmer M, Nonnecke B, Thacker T, Capinos Scherer C, Estes D . Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. Vaccine. 2009; 27(8):1201-9. PMC: 2750035. DOI: 10.1016/j.vaccine.2008.12.018. View

Lyashchenko K, Whelan A, Greenwald R, Pollock J, Andersen P, Hewinson R . Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis. Infect Immun. 2004; 72(5):2462-7. PMC: 387859. DOI: 10.1128/IAI.72.5.2462-2467.2004. View

Orenstein W, Bernier R, Dondero T, Hinman A, Marks J, Bart K . Field evaluation of vaccine efficacy. Bull World Health Organ. 1985; 63(6):1055-68. PMC: 2536484. View

WADDINGTON F, Ellwood D . An experiment to challenge the resistance to tuberculosis in B.C.G. vaccinated cattle in Malawi. Br Vet J. 1972; 128(11):541-52. DOI: 10.1016/s0007-1935(17)36683-6. View

Buddle B, de Lisle G, Pfeffer A, Aldwell F . Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine. 1995; 13(12):1123-30. DOI: 10.1016/0264-410x(94)00055-r. View

Berggren S . Incidence of tuberculosis in BCG vaccinated and control cattle in relation to age distribution in Malawi. Br Vet J. 1977; 133(5):490-4. DOI: 10.1016/s0007-1935(17)33991-x. View

Lopez-Valencia G, Renteria-Evangelista T, Williams J, Licea-Navarro A, Mora-Valle A, Medina-Basulto G . Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. Res Vet Sci. 2009; 88(1):44-9. DOI: 10.1016/j.rvsc.2009.05.022. View

10.

Buddle B, Wedlock D, Denis M, Skinner M . Identification of immune response correlates for protection against bovine tuberculosis. Vet Immunol Immunopathol. 2005; 108(1-2):45-51. DOI: 10.1016/j.vetimm.2005.08.002. View

11.

Buddle B, Skinner M, Chambers M . Immunological approaches to the control of tuberculosis in wildlife reservoirs. Vet Immunol Immunopathol. 2000; 74(1-2):1-16. DOI: 10.1016/s0165-2427(00)00163-x. View

12.

Neill S, Bryson D, Pollock J . Pathogenesis of tuberculosis in cattle. Tuberculosis (Edinb). 2001; 81(1-2):79-86. DOI: 10.1054/tube.2000.0279. View

13.

Ameni G, Aseffa A, Engers H, Young D, Hewinson G, Vordermeier M . Cattle husbandry in Ethiopia is a predominant factor affecting the pathology of bovine tuberculosis and gamma interferon responses to mycobacterial antigens. Clin Vaccine Immunol. 2006; 13(9):1030-6. PMC: 1563579. DOI: 10.1128/CVI.00134-06. View

14.

Vordermeier H, Whelan A, Cockle P, Farrant L, Palmer N, Hewinson R . Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol. 2001; 8(3):571-8. PMC: 96103. DOI: 10.1128/CDLI.8.3.571-578.2001. View

15.

Berggren S . Field experiment with BCG vaccine in Malawi. Br Vet J. 1981; 137(1):88-96. DOI: 10.1016/s0007-1935(17)31792-x. View

16.

Vordermeier H, Huygen K, Singh M, Hewinson R, Xing Z . Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG. Infect Immun. 2006; 74(2):1416-8. PMC: 1360309. DOI: 10.1128/IAI.74.2.1416-1418.2006. View

17.

Vordermeier H, Chambers M, Cockle P, Whelan A, Simmons J, Hewinson R . Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002; 70(6):3026-32. PMC: 128013. DOI: 10.1128/IAI.70.6.3026-3032.2002. View

18.

Ashford D, Whitney E, Raghunathan P, Cosivi O . Epidemiology of selected mycobacteria that infect humans and other animals. Rev Sci Tech. 2001; 20(1):325-37. DOI: 10.20506/rst.20.1.1266. View

19.

Ellwood D, WADDINGTON F . A second experiment to challenge the resistance to tuberculosis in B.C.G. vaccinated cattle in Malawi. Br Vet J. 1972; 128(12):619-26. DOI: 10.1016/s0007-1935(17)36634-4. View

20.

Buddle B, Keen D, Thomson A, Jowett G, McCarthy A, Heslop J . Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci. 1995; 59(1):10-6. DOI: 10.1016/0034-5288(95)90023-3. View